Moreover, both in vitro and in vivo experiments have shown that TSF@ES‐Cu can induce the remodeling of the tumor immune microenvironment, including promoting the maturation of DCs, increasing tumor infiltration of CD8+T cells, and reducing the M2 ratio. This evidence concerns the gene CD8A and neoplasm.